stocks

Stock Market Today: Another Vaccine-Trial Stumble Clips Wall Street's Optimism

Johnson & Johnson (JNJ) paused a vaccine study, and Eli Lilly (LLY) was forced to do the same on a treatment trial, hampering stocks Tuesday.

Investors had plenty to chew on Tuesday, and it showed in a down day for stocks.

The big headline out of the gate was Johnson & Johnson (JNJ, -2.3%) pausing late-stage trials for its promising COVID-19 vaccine due to an "unexplained illness," which, as we explained when AstraZeneca (AZN) was forced to do the same, isn't uncommon and doesn't necessarily spell doom for the treatment.

"JNJ decided to temporarily halt all dosing of the Covid-19 vaccine candidate due to an unexplained illness in a volunteer in the study," writes CFRA's Sel Hardy, who nonetheless maintained a Strong Buy rating on JNJ and upgraded earnings estimates after the company's strong third-quarter earnings results. "We welcome JNJ's transparency and expect to see further clarity as the issue is examined by an independent board."

Meanwhile, stimulus talks remained muddy; Senate Majority Leader Mitch McConnell said his chamber would vote on a bill centered around the Paycheck Protection Program (PPP) sometime this month, though it's uncertain whether it would get past the House.

Apple (AAPL, -2.7%) gave up a little of its recent gains after it unveiled a suite of four new iPhones, including an iPhone 12 Mini with a 5.4-inch screen. And JPMorgan Chase (JPM, -1.6%), which kicked off the Q3 earnings calendar by beating expectations, still slumped as CEO Jamie Dimon warned more stimulus is needed to help the economy.

The Dow Jones Industrial Average slipped 0.6% to 28,679.

Other action in the stock market today:

  • The Nasdaq Composite managed a mere 0.1% decline to 11,863.
  • The S&P 500 fell 0.6% to 3,511.
  • The small-cap Russell 2000 lost 0.7% to 1,636.

COVID Treatments' Push and Pull on Wall Street

The broader market results don't indicate much fallout from today's disappointing COVID-19 news, which also included a halt to Eli Lilly's (LLY, -2.9%) antibody treatment.

But take a closer look: Industrials, real estate, banks and energy, which rely heavily on robust economic activity, were solidly lower today. However, technology and communications once again showed relative strength as they have all year, bolstering the fortunes of technology funds such as these 15 products, and that should continue to be the case as long as effective treatments and vaccines remain elusive.

The same goes for the Invesco QQQ Trust (QQQ), which invests in the index composed of the Nasdaq's 100 largest financials and has raked in billions in assets this year, prompting Invesco to launch even more funds tied to the index. (You can read about a host of Nasdaq-100 products here.)

At some point, however, a vaccine or treatment will finally get the green light, and while it might take months to reach most of America's population, most experts expect that to "flip the switch" for a host of battered industries. Here, we look at 11 stocks to buy that are in rough shape right now, but that could pivot in a heartbeat when a game-changing medical breakthrough is announced.

Kyle Woodley was long AAPL and QQQ as of this writing.

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
How to Calculate the Break-Even Age for Taking Social Security
social security

How to Calculate the Break-Even Age for Taking Social Security

When it comes to maximizing your Social Security benefits, there are many elements to consider. One factor that can be especially enlightening is your…
August 30, 2021
Spend Without Worry in Retirement
Financial Planning

Spend Without Worry in Retirement

Fears of running out of money prevent many retirees from tapping the nest egg they’ve worked a lifetime to save. With these strategies, you can genera…
August 30, 2021

Recommended

Stock Market Today (9/16/21): Stocks Weeble, Wobble, But Finish Mostly Flat
Stock Market Today

Stock Market Today (9/16/21): Stocks Weeble, Wobble, But Finish Mostly Flat

An up-and-down session Thursday finished with muted results despite a volley of encouraging economic signals.
September 16, 2021
Stock Market Today (9/15/21): Energy Leads Broad Market Snap-Back
Stock Market Today

Stock Market Today (9/15/21): Energy Leads Broad Market Snap-Back

Upbeat economic data helped provide a tailwind for most stocks, but energy really shone as tight inventories sent oil prices soaring.
September 15, 2021
5 Medtech Stocks to Seize Major Growth
stocks

5 Medtech Stocks to Seize Major Growth

The merging of healthcare and technology is changing how we care for our bodies. It's also creating investment opportunities, such as these five medic…
September 15, 2021
Stock Market Today (9/14/21): Dow Drops as Brief Boost From CPI Data Fades
Stock Market Today

Stock Market Today (9/14/21): Dow Drops as Brief Boost From CPI Data Fades

A morning jolt from an August cooldown in inflation proved ephemeral Tuesday, with early gains fizzling into widespread declines.
September 14, 2021